The Central Pharmaceutical Standards Control Organization (CDSCO) will make rules for prescription drug or over-the-counter (OTC) medicines without prescription.
Under the scheme, clear rules regarding the drug that can be sold without a doctor's prescription will be decided. India's Drug Controller General GN Singh said that there is a possibility of misuse of high-risk drugs without having any separate regulation. Here are the names of those drugs which can not be sold as OTC.
Currently, the drugs have been classified in Schedule X, H, H1, G and K, whose sale can not be done without the prescription of the doctors. The government is also planning to ask chemists to stamp their doctor's slip so that the slip can not be used again. New guidelines for OTC medicines are being brought to prevent anti-microbial resistors due to excessive use of these drugs. The drug controller is also trying to make them friendly to international standards, because developed countries There are different rules for OTC products. Government will make changes in the drug and cosmetics rules for this. The drug counseling committee will currently consider drugs in class X, H, H1, G and category.
Drugs in this category are considered to be high risk and they work in the treatment of deadly disease like cancer. All India Chemists and Drugsticks Federation has the opinion that the government should fix the margins of OTC medicines and there should be very low margins on such products. Domestic pharma companies are focusing on the OTC segment to increase sales. They are removing old brands of physicians' slip in the market to remove the softness in the sale or are acquiring such brands. The domestic sales growth of the industry has come down to 5.5% in 2017, which is the lowest in eight years. Upon the introduction of old drugs into the OTC category, companies are helping to increase sales. According to a report by Nicholas Hall, the OTC market in India in 2016 was Rs 18860 crore. It is estimated to increase from its annual growth rate of 9% to Rs. 44110 crores by 2026.
Under the scheme, clear rules regarding the drug that can be sold without a doctor's prescription will be decided. India's Drug Controller General GN Singh said that there is a possibility of misuse of high-risk drugs without having any separate regulation. Here are the names of those drugs which can not be sold as OTC.
Currently, the drugs have been classified in Schedule X, H, H1, G and K, whose sale can not be done without the prescription of the doctors. The government is also planning to ask chemists to stamp their doctor's slip so that the slip can not be used again. New guidelines for OTC medicines are being brought to prevent anti-microbial resistors due to excessive use of these drugs. The drug controller is also trying to make them friendly to international standards, because developed countries There are different rules for OTC products. Government will make changes in the drug and cosmetics rules for this. The drug counseling committee will currently consider drugs in class X, H, H1, G and category.
Drugs in this category are considered to be high risk and they work in the treatment of deadly disease like cancer. All India Chemists and Drugsticks Federation has the opinion that the government should fix the margins of OTC medicines and there should be very low margins on such products. Domestic pharma companies are focusing on the OTC segment to increase sales. They are removing old brands of physicians' slip in the market to remove the softness in the sale or are acquiring such brands. The domestic sales growth of the industry has come down to 5.5% in 2017, which is the lowest in eight years. Upon the introduction of old drugs into the OTC category, companies are helping to increase sales. According to a report by Nicholas Hall, the OTC market in India in 2016 was Rs 18860 crore. It is estimated to increase from its annual growth rate of 9% to Rs. 44110 crores by 2026.